Dr
KK Aggarwal
Vide
a notification F. No. X. 11014/8/2019-DR issued on the 19th July, 2019, the
Ministry of Health and Family Welfare has prohibit the manufacture, sale and
distribution of the drug Colistin and its formulations for food producing
animals, poultry, aqua farming and animal feed supplements.
The
notification reads as follows:
“And whereas, the Central Government is satisfied that it is
necessary and expedient in the public interest to prohibit the manufacture,
sale and distribution of the drug Colistin and its formulations for food
producing animals, poultry, aqua farming and animal feed supplements;
Now, therefore, in exercise of powers conferred by section 26A of the
Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government hereby―
a) prohibits the manufacture, sale and distribution of the following
drug with immediate effect, namely:― “Colistin and its formulations for food
producing animals, poultry, aqua farming and animal feed supplements”; and
(b) directs that the manufacturer of Colistin and its formulations shall
label the container of the drug and mention the words “NOT TO BE USED IN FOOD
PRODUCING ANIMALS, POULTRY, AQUA FARMING AND ANIMAL FEED SUPPLEMENTS” in
conspicuous manner on the package insert and promotional literature of the said
drug and its formulations.”
An
update on colistin published in the journal Expert
Review of Anti-infective Therapy in 2012 stated that “colistin
probably will be the 'last-line' therapeutic drug against multidrug-resistant
Gram-negative pathogens in the 21st century” (Expert Rev Anti Infect
Ther. 2012;10(8):917-934). However, emergence of resistance to this “last
resort” drug in Enterobacteriaceae is a cause of concern.
Track our earlier published story on this issue:
Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of
Medical Associations in Asia and Oceania
(CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of
India
Past National President
IMA
No comments:
Post a Comment